Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 2040-2041, 2007; 10.1373/clinchem.2007.094466
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gambino, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gambino, R.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2007;53:2040-2041.)
© 2007 American Association for Clinical Chemistry, Inc.

Opinion

Glucose: A Simple Molecule That Is Not Simple to Quantify

Raymond Gambino

Quest Diagnostics, Inc., 1300 East Newport Center Dr., Deerfield Beach, FL 33442-7727, Fax 954-281-3873, E-mail doclab@aol.com.

The first 20% of the full text of this article appears below.

Small increments in blood glucose substantially increase the risk of developing diabetes mellitus; but preanalytical and analytical variables, such as the absence of harmonization for glucose assays, make it difficult to correctly apply these epidemiological insights to individual patients. Harmonization can be improved if 3 variables are addressed: changing proficiency test grading from consensus based to accuracy based, effectively controlling glycolysis, and taking into account the time of day blood was collected.

The continuous and graded quantitative relationship of fasting glucose measurements to the risk of developing diabetes was well documented recently by Tirosh et al.(1). They found an increased risk of type 2 diabetes across quintiles of fasting plasma glucose (FPG) concentrations within the newly defined reference range, <5.55 mmol/L (<100 mg/dL). For example, a person with an FPG between 4.83 and 5.00 mmol/L (87 and 90 mg/dL) has an age-adjusted risk of developing diabetes that is 1.81 times that of a person with an FPG <4.55 mmol/L (82 mg/dL; 95% CI 1.16–2.83). Thus, a difference as small as 0.28 mmol/L (5 mg/dL) nearly doubles the risk. Higher concentrations of . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
L. M. Mikesh and D. E. Bruns
Stabilization of Glucose in Blood Specimens: Mechanism of Delay in Fluoride Inhibition of Glycolysis
Clin. Chem., May 1, 2008; 54(5): 930 - 932.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.